ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 762

Inhibition Of TGF-Beta Signaling In Articular Chondrocytes Leads To OA-Like Pathological Defects and Pain-Related Behavior Change In Mice

Jia Li1, Jie Shen2, Shan Li1, John Dickerson1, Jeffrey Kroin1, Hee-Jeong Im1 and Di Chen1, 1Rush University, Chicago, IL, 2University of Rochester, Rochester, NY

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: matrix metalloproteinase (MMP), osteoarthritis and transforming growth factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR Plenary Session I: Discovery 2013

Session Type: Plenary Sessions

Background/Purpose: TGF-β signaling plays an important role in chondrocyte differentiation and osteoarthritis (OA) pathogenesis.  However TGF-β downstream target genes and signaling mechanism in OA development remains poorly understood.  In the present studies, we investigated TGF-β signaling in OA development. 

Methods: Tgfbr2 conditional knockout (Tgfbr2Col2ER) mice were generated by breeding Tgfbr2flox/flox mice with Col2-CreER transgenic mice.  Deletion of the Tgfbr2 gene was achieved by administration of tamoxifen into 2-week-old Tgfbr2Col2ER mice.  Changes in histology, gene expression and pain-related behavior were analyzed.  Tgfbr2/Mmp13 and Tgfbr2/Adamts5 double KO mice were generated by breeding Tgfbr2Col2ER mice with Mmp13flox/flox mice and Adamts5-/- mice.

Results: Deletion of the Tgfbr2 gene in articular chondrocytes resulted in up-regulation of Runx2, Atf4, Mmp13, Adamts5 and Col10 expression.  Histological analysis showed articular cartilage degradation, increased chondrocyte hypertrophy in superficial zone, early osteophyte formation, and increased subchondral bone mass in 3-month-old Tgfbr2Col2ER mice.  Loss of entire articular cartilage, formation of extensive osteophytes, and substantially increased subchondral bone mass were observed in 6-month-old Tgfbr2Col2ER mice.  Histomorphometric analysis and evaluation with OARSI scoring system showed a significant decrease in articular cartilage area in Tgfbr2Col2ER mice.  Significant reduction in spontaneous rearing activity and ambulation counts were also observed in 4-, 5-, 6-, 7-, and 8-month-old Tgfbr2Col2ER mice.  To determine if up-regulation of Mmp13 and Adamts5 expression is responsible for Tgfbr2Col2ER-induced OA development, we generated Tgfbr2/Mmp13 and Tgfbr2/Adamts5 double KO mice.  Deletion of the Mmp13 gene significantly alleviates OA-like pathological changes observed in 3- and 6-month-old Tgfbr2Col2ER mice.  In contrast, deletion of the Adamts5 gene only reversed OA-like phenotype in 3-month-old Tgfbr2Col2ER mice.  These changes were confirmed by histomorphometric analysis and by evaluation with OARSI scoring system.  We also investigated the signaling mechanism and found that inhibition of TGF-β signaling prevented Runx2 degradation.  Runx2 directly bound to its binding site located in the proximal region of the Mmp13 promoter and activated Mmp13 transcription.  ATF4 interacted with Runx2 and enhanced Runx2-induced Mmp13 transcription. 

Conclusion: In this study, we demonstrate that inhibition of TGF-β signaling in articular chondrocytes leads to a progressive OA-like phenotype in mice.  Mmp13 and Adamts5 are critical downstream target genes of TGF-β signaling during OA development.


Disclosure:

J. Li,
None;

J. Shen,
None;

S. Li,
None;

J. Dickerson,
None;

J. Kroin,
None;

H. J. Im,
None;

D. Chen,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhibition-of-tgf-beta-signaling-in-articular-chondrocytes-leads-to-oa-like-pathological-defects-and-pain-related-behavior-change-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology